Organogenesis Holdings Inc's Comment on Supply Chain
The company relies on a limited number of suppliers and manufacturers for its products, including Apligraf, Affinity, CYGNUS, Novachor, NuShield, and PuraPly Antimicrobial. Components are sourced from suppliers who must comply with regulatory requirements, agreed specifications, cost parameters, and delivery schedules. Disruptions in manufacturing or loss of suppliers could result in significant delays, increased costs, or an inability to obtain necessary materials, adversely affecting the company's operations and financial condition. Due to FDA regulations, the company faces challenges in rapidly identifying replacement sources. Suppliers may also restrict or deny credit, which could impact purchasing capabilities. Disruptions involving sole-source suppliers or loss of exclusive supply contracts could materially harm the business. Furthermore, product availability depends on tissue from human donors, and any disruption in this supply could negatively affect operations.
Organogenesis Holdings Inc's Comment on Supply Chain
The company relies on a limited number of suppliers and manufacturers for its products, including Apligraf, Affinity, CYGNUS, Novachor, NuShield, and PuraPly Antimicrobial. Components are sourced from suppliers who must comply with regulatory requirements, agreed specifications, cost parameters, and delivery schedules. Disruptions in manufacturing or loss of suppliers could result in significant delays, increased costs, or an inability to obtain necessary materials, adversely affecting the company's operations and financial condition. Due to FDA regulations, the company faces challenges in rapidly identifying replacement sources. Suppliers may also restrict or deny credit, which could impact purchasing capabilities. Disruptions involving sole-source suppliers or loss of exclusive supply contracts could materially harm the business. Furthermore, product availability depends on tissue from human donors, and any disruption in this supply could negatively affect operations.
Sources:
Organogenesis Holdings Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Organogenesis Holdings Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
